BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566 AND Staging
16 results:

  • 1. Development and External Validation of a Nomogram Including Body Composition Parameters for Predicting Early Recurrence of Hepatocellular Carcinoma After Hepatectomy.
    Shi S; Zhao YX; Fan JL; Chang LY; Yu DX
    Acad Radiol; 2023 Dec; 30(12):2940-2953. PubMed ID: 37798207
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Development and Validation of Prognostic Nomograms for Lung Squamous Cell Carcinoma With Brain Metastasis in Patients Aged 45 Years or Older: A Population-Based Study.
    Yang F; Gao L; Wang Q; Gao W
    Cancer Control; 2023; 30():10732748231202953. PubMed ID: 37776257
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Lung immune prognostic index‑based nomogram for recurrence of hepatocellular carcinoma after postoperative adjuvant TACE.
    Liang Y; Yang R; Shang J; Zhong D; Yang Q; Su Y; Shi Y; Huang X
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16461-16471. PubMed ID: 37707573
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic Role of Low-Skeletal Muscle Mass on staging Computed Tomography in Metastasized Colorectal cancer: A Systematic Review and Meta-Analysis.
    Meyer HJ; Strobel A; Wienke A; Surov A
    Clin Colorectal Cancer; 2022 Sep; 21(3):e213-e225. PubMed ID: 35792019
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma.
    Zheng W; Zhu W; Yu S; Li K; Ding Y; Wu Q; Tang Q; Zhao Q; Lu C; Guo C
    BMC Cancer; 2020 Nov; 20(1):1066. PubMed ID: 33148204
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Validation of the American Joint Committee on cancer 8th edition staging system for the pancreatic ductal adenocarcinoma.
    Shin DW; Lee JC; Kim J; Woo SM; Lee WJ; Han SS; Park SJ; Choi KS; Cha HS; Yoon YS; Han HS; Hong EK; Hwang JH
    Eur J Surg Oncol; 2019 Nov; 45(11):2159-2165. PubMed ID: 31202572
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Novel Prognostic Nomograms Based on Inflammation-Related Markers for Patients with Hepatocellular Carcinoma Underwent Hepatectomy.
    Wang Y; Sun K; Shen J; Li B; Kuang M; Cao Q; Peng S
    Cancer Res Treat; 2019 Oct; 51(4):1464-1478. PubMed ID: 30913869
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Validation of the American Joint Committee on cancer eighth edition staging system in patients undergoing hepatectomy for hepatocellular carcinoma: a US population-based study.
    Zhang G; Li R; Zhao X; Meng S; Ye J; Zhao L
    J Surg Res; 2018 Feb; 222():55-68. PubMed ID: 29273376
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Nomogram to Predict Survival of Patients With Recurrence of Hepatocellular Carcinoma After Surgery.
    He W; Peng B; Tang Y; Yang J; Zheng Y; Qiu J; Zou R; Shen J; Li B; Yuan Y
    Clin Gastroenterol Hepatol; 2018 May; 16(5):756-764.e10. PubMed ID: 29246702
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Noninvasive markers for staging fibrosis in chronic delta hepatitis.
    Takyar V; Surana P; Kleiner DE; Wilkins K; Hoofnagle JH; Liang TJ; Heller T; Koh C
    Aliment Pharmacol Ther; 2017 Jan; 45(1):127-138. PubMed ID: 27813124
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Ultrasound surveillance for hepatocellular carcinoma: real-life performance in a hepatology outpatient clinic.
    Frey RS; Boldanova T; Heim M
    Swiss Med Wkly; 2015; 145():w14200. PubMed ID: 26588016
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B.
    Park MS; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Shin SH; Kang W; Moon C; Han KH
    Liver Int; 2015 Feb; 35(2):455-62. PubMed ID: 25183426
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Impact of histologically confirmed lymph node metastases on patient survival after surgical resection for hepatocellular carcinoma: report of a Japanese nationwide survey.
    Hasegawa K; Makuuchi M; Kokudo N; Izumi N; Ichida T; Kudo M; Ku Y; Sakamoto M; Nakashima O; Matsui O; Matsuyama Y;
    Ann Surg; 2014 Jan; 259(1):166-70. PubMed ID: 23532111
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long-term clinical outcomes of 1717 treatment-naïve patients with hepatocellular carcinoma.
    Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Park MS; Kim EH; Seong J; Lee DY; Han KH
    Liver Int; 2012 Aug; 32(7):1120-7. PubMed ID: 22524688
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma.
    Chun YH; Kim SU; Park JY; Kim DY; Han KH; Chon CY; Kim BK; Choi GH; Kim KS; Choi JS; Ahn SH
    Eur J Cancer; 2011 Nov; 47(17):2568-75. PubMed ID: 21835608
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Incidence and risk factors for the development of lung tumors after liver transplantation.
    Jiménez C; Manrique A; Marqués E; Ortega P; Loinaz C; Gómez R; Meneu JC; Abradelo M; Moreno A; López A; Moreno E
    Transpl Int; 2007 Jan; 20(1):57-63. PubMed ID: 17181654
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.